Please try another search
BPH Energy Limited invests in biotechnology, oil and gas exploration and development, and medicinal cannabis industries in Australia. The company is building a system to generate clean hydrogen and conductive carbon used to manufacture batteries for commercial use. It also offers brain anaesthesia response monitoring system, a device to detect the effect of anaesthetic agents on brain activity and assist anaesthetists in keeping patients optimally anaesthetised. In addition, the company invests in the biomedical research of HLS5 tumour suppressor gene for liver cancer. Further, it holds a 100% interest in RL1 oil and gas assets located in the onshore Bonaparte basin in northern Australia; and 85% interest in the petroleum exploration permit 11 situated in the offshore Sydney basin. The company was formerly known as BioPharmica Limited. BPH Energy Limited was incorporated in 2001 and is headquartered in Stirling, Australia.
Name | Age | Since | Title |
---|---|---|---|
Stephen Kelemen | - | 2018 | Non-Executive Director |
Steven Craig James | - | 2019 | Non-Executive Director |
David Leslie Breeze | 68 | 2001 | Executive Chairman, MD & Company Secretary |
Anthony Huston | 67 | 2017 | Independent Non-Executive Director |
Charles Verdon Maling | 68 | 2017 | Independent Non-Executive Director |
David Liley | 59 | - | Scientific Advisor |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review